Published in Neurology on January 01, 1993
What to do when a competent ICU patient does not want to live anymore but is dependent on life-sustaining treatment? Experience from The Netherlands. Intensive Care Med (2010) 1.43
The milk and the honey: ethics of artificial nutrition and hydration of the elderly on the other side of Europe. J Med Ethics (1999) 0.97
Withholding therapy. Neurology (1993) 0.75
Withholding therapy. Neurology (1993) 0.75
The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20
The physician's responsibility toward hopelessly ill patients. N Engl J Med (1984) 2.46
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry (1996) 2.30
Withdrawing artificial feeding from children with brain damage. BMJ (1995) 1.91
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science (1976) 1.76
DNA-triplet repeats and neurologic disease. N Engl J Med (1996) 1.60
Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology (1967) 1.50
Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions. Alzheimer Dis Assoc Disord (2004) 1.48
Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med (1982) 1.31
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci U S A (1981) 1.28
Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology (1976) 1.27
Markers for gene expression in cultured cells from the nervous system. J Biol Chem (1972) 1.26
Transverse myelitis associated with heroin addiction. JAMA (1968) 1.22
Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology (1995) 1.21
Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology (1978) 1.21
Effects of practice on category fluency in Alzheimer's disease. Clin Neuropsychol (2001) 1.20
Apoptosis and neurologic disease. Am J Med (2000) 1.17
Mononeuritis multiplex in lepromatous leprosy. Arch Neurol (1968) 1.12
Forgoing medically provided nutrition and hydration in pediatric patients. J Law Med Ethics (1995) 1.12
The implications and applications of institutional ethics committees. Bull Am Coll Surg (1985) 1.11
Neurologic involvement in Urbach-Wiethe's disease (lipoid proteinosis). A clinical, ultrastructural, and chemical study. Neurology (1971) 1.07
Brain death laws and patterns of consent to remove organs for transplantation from cadavers in the United States and 28 other countries. Transplantation (1981) 1.07
Institutional ethics committees: issues of confidentiality and immunity. Law Med Health Care (1985) 1.06
Platelet APP isoform ratios correlate with declining cognition in AD. Neurology (2000) 1.01
Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities. Arch Neurol (1974) 1.01
Comparison of the hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease. Appl Neuropsychol (2001) 1.00
Neurological complications of fibrous dysplasia of the skull. Arch Neurol (1968) 0.99
Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands. Adv Neurol (1978) 0.97
The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci (1984) 0.97
Hospital ethics committees. Administrative aspects. JAMA (1985) 0.97
Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol (1978) 0.97
Michael Martin and Robert Wendland: beyond the vegetative state. J Contemp Health Law Policy (1999) 0.95
Glial tumor metastases through a ventriculo-pleural shunt. Resultant massive pleural effusion. Arch Neurol (1968) 0.94
The Machado-Joseph disease locus is different from the spinocerebellar ataxia locus (SCA1). Genomics (1992) 0.94
Treatment of acute seizures and status epilepticus with intravenous phenytoin. Adv Neurol (1983) 0.92
Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry (1999) 0.91
Vasoactive intestinal polypeptide in brain synaptosomes. Lancet (1976) 0.91
Progressive ophthalmoplegia. Report of cases. Arch Neurol (1968) 0.90
Prion proteins: a biological role beyond prion diseases. Acta Neurol Scand (2007) 0.90
Joseph disease: an autosomal dominant motor system degeneration. Adv Neurol (1984) 0.90
Differences in the distribution of poly(A) size classes in individual messenger RNAs from neuroblastoma cells. J Biol Chem (1979) 0.89
Physiology of glia: glial-neuronal interactions. Int Rev Neurobiol (1979) 0.88
Frontal lobe ataxia. Surg Neurol (1995) 0.87
Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma. Mol Pharmacol (1975) 0.86
Intravenous phenytoin in acute treatment of seizures. Neurology (1979) 0.85
Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients. Neurology (2003) 0.85
A radioisotopic, chromatographic microassay for acetyl-coenzyme A synthetase and some preliminary studies on the rat brain enzyme. Biochim Biophys Acta (1973) 0.85
Thyrotoxic periodic paralysis with upper motor neuron findings. JAMA (1978) 0.84
Autosomal dominant progressive syndrome of motor-speech loss without dementia. Neurology (1997) 0.84
Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures. J Neurol Sci (1997) 0.84
Induction of adenosine 3',5'-monophosphate binding proteins by N6,O2'-dibutyryladenosine 3',5'-monophosphate in mouse neuroblastoma cells. Analysis by two-dimensional gel electrophoresis. Biochemistry (1979) 0.84
Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids. Neurology (1978) 0.83
Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Neurology (1987) 0.83
Regulation of the synthesis of choline-O-acetyltransferase and thymidylate synthetase in mouse neuroblastoma in cell culture. Proc Natl Acad Sci U S A (1971) 0.82
Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus. J Med Genet (1995) 0.82
Specific messenger RNA changes in Joseph disease cerebella. Ann Neurol (1983) 0.82
Some critical distinctions between brain death and the persistent vegetative state. Ethics Sci Med (1979) 0.82
Idiopathic polyneuropathy associated with cytotoxic anti-neuroblastoma serum. IgG and IgM immunoglobulin studies. Neurology (1975) 0.81
Furosemide-sensitive K+ channel in glioma cells but not neuroblastoma cells in culture. Biochem Biophys Res Commun (1982) 0.81
Altered thymidine kinase or thymidylate synthetase activities in 5-fluoro deoxyuridine resistant variants of mouse neuroblastoma. J Neurochem (1977) 0.81
Quantitation and characterisation of poly(A)-containing messenger RNAs from mouse neuroblastoma cells. Biochim Biophys Acta (1977) 0.81
Corticosteroids in ischemic stroke. Stroke (1979) 0.81
Reye's syndrome: isolation of parainfluenza virus. Report of three cases. Arch Neurol (1973) 0.81
Hypothermia and persisting capacity to develop fever. Occurrence in a patient with sarcoidosis of the central nervous system. Arch Neurol (1977) 0.81
A comparison of thymidylate synthetase activities from 5-fluorodeoxyuridine sensitive and resistant variants of mouse neuroblastoma. J Neurochem (1975) 0.81
An AP-2 binding sequence within exon 1 of human and porcine choline acetyltransferase genes enhances transcription in neural cells. Neuroscience (1997) 0.80
Joseph disease and Huntington disease: protein patterns in fibroblasts and brain. Neurology (1981) 0.80
Induction of cyclic AMP-binding proteins by dibutyryl cyclic AMP in mouse neuroblastoma cells. Biochim Biophys Acta (1978) 0.80
Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture. Mol Pharmacol (1974) 0.79
Sleep apnea and hypoventilation syndrome associated with acquired nonprogressive dysautonomia: clinical and pathological studies in a child. Ann Neurol (1981) 0.79
The emergence of institutional ethics committees. Law Med Health Care (1984) 0.79
Xenon-133 SPECT-determined regional cerebral blood flow in Alzheimer's disease: what is typical? J Neuropsychiatry Clin Neurosci (1993) 0.79
alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings. Neurology (1976) 0.79
Molecular genetics, recombinant DNA techniques, and genetic neurological disease. Ann Neurol (1984) 0.79
Amplification signals anticipation--less DNA is better. Neurology (1992) 0.78
Molecular neurogenetics: the genome is settling the issue. JAMA (1997) 0.78
Recombinant DNA and neurologic disease: the coming of a new age. Neurology (1983) 0.78
Decreased 6-mercaptopurine retention by two resistant variants of mouse neuroblastoma with normal hypoxanthine-guanine-phospho-ribosyltransferase activities. J Pharmacol Exp Ther (1975) 0.78
Comparison of the CERAD and CVLT list-learning tasks in Alzheimer's disease. Clin Neuropsychol (2000) 0.78
Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease. J Clin Endocrinol Metab (1978) 0.78
Neurologic syndromes and prolonged survival: when can artificial nutrition and hydration be forgone? Law Med Health Care (1991) 0.77
Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus. Hum Genet (1994) 0.77
Genomic neurology: a new beginning. Arch Neurol (2001) 0.76
Morphological differentiation and proteoglycan synthesis regulate Alzheimer amyloid precursor protein processing in PC-12 and human astrocyte cultures. J Neurosci Res (1992) 0.76
Neurotherapeutics, evidence-based neurology, and clinical equipoise. Arch Neurol (1999) 0.76
Erroneous diagnosis corrected after 28 years. Not spinal muscular atrophy with ophthalmoplegia but minicore myopathy. Arch Neurol (1996) 0.76
Memory loss--when is it Alzheimer disease? JAMA (1998) 0.76
Minnesota Medical Association Criteria. Brain death. Concept and criteria. Minn Med (1978) 0.76
The 1990s--decade of the brain: the need for a national priority. Neurology (1990) 0.76
Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist (1998) 0.76
Urine vapor pattern for olivopontocerebellar degeneration. Clin Biochem (1975) 0.76
Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutation. J Neurol Sci (2001) 0.76
Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells. J Neurosci Res (1991) 0.76
Effect of norepinephrine on glucose metabolism in glioblastoma and neuroblastoma cells in cell culture. Proc Natl Acad Sci U S A (1972) 0.75
Treatment of cerebral edema. Calif Med (1971) 0.75
Spinocerebellar ataxias and ataxins. N Engl J Med (1995) 0.75
Defining the neurological basis of the Gulf War syndrome. Arch Neurol (2000) 0.75
Presidential judgment. The twenty-fifth amendment. Arch Neurol (1997) 0.75
Commentary on the practice parameters for the persistent vegetative state. Neurology (1995) 0.75
Brain death. Concept and criteria. Minn Med (1978) 0.75